Seeing Is Believing
with an average price target of $36.94. This is a potential upside of $4.46 (13.73%) from yesterday's end of day stock price of $32.48.
Cymabay Therapeu's activity chart (see below) currently has 183 price targets and 127 ratings on display.
Analysts average stock forecasts to be materialized ratio is 84.08% with an average time for these price targets to be met of 713.5 days.
Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 28-Feb-2024.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$32.5
$0.02 (0.06%)
1 years 7 months 11 days ago
(28-Feb-2024)
17/18 (94.44%)
$0.31 (0.96%)
627
Hold
$32.5
$0.02 (0.06%)
$12
1 years 7 months 20 days ago
(19-Feb-2024)
2/3 (66.67%)
$0.3 (0.93%)
129
Hold
$32.5
$0.02 (0.06%)
$25
1 years 7 months 26 days ago
(13-Feb-2024)
8/9 (88.89%)
$0.32 (0.99%)
891
Hold
$32.5
$0.02 (0.06%)
$34
1 years 7 months 27 days ago
(12-Feb-2024)
9/12 (75%)
$0.38 (1.18%)
1210
Hold
$32.5
$0.02 (0.06%)
$33
1 years 7 months 27 days ago
(12-Feb-2024)
13/15 (86.67%)
$0.38 (1.18%)
908
What is CBAY (Cymabay Therapeu) average time for price targets to be met?
Which analyst has the current highest performing score on CBAY (Cymabay Therapeu) with a proven track record?
Which analyst has the most public recommendations on CBAY (Cymabay Therapeu)?
Which analyst is the currently most bullish on CBAY (Cymabay Therapeu)?
Which analyst is the currently most reserved on CBAY (Cymabay Therapeu)?